Evidence map›Paper›PMID 40498238›Full record

SynthesisAIDS and behavior2025

The Effect of Sexual and Gender Minority Violence on Depression, Hazardous Drinking, Condom Use, and HIV Acquisition: An Individual Participant Data Meta-Analysis of the CohMSM, HPTN 075, and Anza Mapema Cohort Studies in Africa.

James Stannah, Jesse Knight, Theo Sandfort, Christian Laurent, Fredrick O Otieno, Joseph Larmarange, Pierre-Julien Coulaud, Victor Mudhune, Erica Hamilton, Vanessa Cummings and 9 more

Abstract readMeta-Analysis
In one paragraph

Synthesis in AIDS and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

James StannahSchool of Population and Global Health, McGill University, Montréal, H3A 1G1, Canada.
Jesse KnightMedical Research Council Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.
Theo SandfortDivision of Gender, Sexuality and Health, New York State Psychiatric Institute and Columbia University, New York, USA.
Christian LaurentTransVIHMI, Université Montpellier, Institut de Recherche pour le Développement, INSERM, Montpellier, France.
Fredrick O OtienoNyanza Reproductive Health Society, Kisumu, Kenya.
Joseph LarmarangeCentre Population et Développement, Université Paris Cité, Institut de Recherche pour le Développement, Inserm, Paris, France.
Pierre-Julien CoulaudCentre for Epidemiology and Research in Population Health (CERPOP), Université de Toulouse, Université Paul Sabatier, Inserm, Toulouse, France.
Victor MudhuneCentre for Global Health Research, Kenya Medical Research Institute (KEMRI), Kisumu, Kenya.
Erica HamiltonNetwork and Collaborative Research Division, Durham, NC, FHI 360, USA.
Vanessa CummingsDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Bruno SpireSESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, Aix Marseille Univ, IRD, ISSPAM, Inserm, Marseille, France.
Doerieyah ReynoldsDesmond Tutu Health Centre, Cape Town, South Africa.
Sufia DadabhaiJohns Hopkins Research Project, Kamuzu University of Health Sciences, Blantyre, Malawi.
Duncan OkallNyanza Reproductive Health Society, Kisumu, Kenya.
Bintou Dembélé KeitaARCAD Santé PLUS, Centre Intégré de Recherche, de Soins et d'Action Communautaire, Bamako, Mali.
Luis Sagaon-TeyssierSESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, Aix Marseille Univ, IRD, ISSPAM, Inserm, Marseille, France.
Ravindre PanchiaPerinatal HIV Research Unit, University of the Witwatersrand, Soweto, South Africa.
Marie-Claude BoilyMedical Research Council Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.
Mathieu Maheu-GirouxSchool of Population and Global Health, McGill University, Montréal, H3A 1G1, Canada. mathieu.maheu-giroux@mcgill.ca.ORCID http://orcid.org/0000-0002-8363-4388

Funding

LOC: HIV Prevention Trials NetworkUM1AI068619 · NIAID · FAMILY HEALTH INTERNATIONAL · PI MYRON Scott COHEN, Sinead Delany-Moretlwe · 2011 to 2026
$779.5M
SDMC: HPTN 084 Pregnancy SupplementUM1AI068617 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Elizabeth Renata Brown, Deborah J Donnell · 2011 to 2026
$204.9M
LC: HIV Prevention Trials Network - Laboratory Support for the SARS-CoV-2 Seroprevalence Study (CoVPN 5002)UM1AI068613 · NIAID · JOHNS HOPKINS UNIVERSITY · PI SUSAN H ESHLEMAN, Mark A Marzinke · 2011 to 2026
$100.2M
The Statistics, Data Science, and Data Management (SDM) CoreP30MH043520 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI MILTON L WAINBERG · 2003 to 2026
$48.2M
The Malawi Clinical Trials UnitUM1AI069518 · NIAID · JOHNS HOPKINS UNIVERSITY · PI JACKY M JENNINGS, TAHA E TAHA · 2012 to 2026
$43.8M
In-depth Understanding of HIV Risk Behavior among Men Who Have Sex With Men in Sub-Saharan Africa: Secondary Analysis of HPTN 075 DataR21MH130217 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI SANDFORT, THEODORUS G.M. · 2022 to 2023
$455k
Fondation pour la Recherche Médicale ARF202309017482Medical Research Council MR/X020258/ 1NIAID NIH HHS UM1 AI068613NIAID NIH HHS UM1 AI068617NIAID NIH HHS UM1 AI068619NIAID NIH HHS UM1 AI069518NIH HHS UM1 AI068613NIH HHS UM1 AI068617NIH HHS UM1 AI068619NIMH NIH HHS P30 MH043520NIMH NIH HHS P30-MH43520NIMH NIH HHS R21 MH130217NIMH NIH HHS R21-MH130217Wellcome TrustWellcome Trust 226619/Z/22/Z
6 · The paper itself

Abstract

Some sexual and gender minorities (SGM), including men who have sex with men and transgender women, are disproportionately vulnerable to HIV. Many SGM in Africa report experiencing verbal or physical violence due to their sexual and/or gender identities or behaviours. The pathways linking such SGM violence to HIV acquisition are complex. We described experiences of verbal and physical SGM violence and explored pathways to HIV acquisition among SGM assigned male sex at birth using a two-stage individual participant data meta-analysis of three African cohort studies: CohMSM (Burkina Faso, Côte d'Ivoire, Mali, Togo), HPTN 075 (Kenya, Malawi, South Africa), and Anza Mapema (Kenya). SGM violence was assessed at baseline and follow-up visits. We fit log-linear sequential conditional mean models using generalised estimating equations to estimate risk ratios linking SGM violence, moderate-to-severe depressive symptoms, hazardous drinking, condom use, and HIV acquisition, adjusted for baseline confounders and previous exposure and outcome. We pooled study estimates using random effects meta-analysis. SGM violence, mostly verbal, was reported by 36% (570/1590) participants at baseline (past 6-12 months), and 20% (321/1590) during the first year of follow-up (past 3-6 months). Baseline SGM violence was not associated with HIV acquisition (pooled adjusted risk ratio [aRR] = 1.0, 95% CI 0.5-1.9). During follow-up, SGM violence also showed no clear relationship with HIV, but was linked to depressive symptoms at the same visit (pooled aRR = 1.7, 1.3-2.1), in turn associated with hazardous drinking (pooled aRR = 1.4, 1.1-1.7). Impacts on condom use were inconclusive. SGM in Africa face high rates of violence, which are associated with depressive symptoms and hazardous drinking-potential routes to HIV vulnerability. While our study did not conclusively demonstrate higher HIV incidence among SGM reporting violence, interventions to reduce violence and support mental health remain crucial.

Indexed as

Alcohol DrinkingCondomsDepressionHIV InfectionsSexual and Gender MinoritiesViolenceAdultAfricaCohort StudiesFemaleHumansMaleSexual BehaviorYoung AdultHIV incidenceHomophobic violenceIndividual participant data meta-analysisMental healthSexual and gender minoritiesStructural determinants

Identifiers

PMID40498238
PMCPMC12237430

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.